Loading news...
Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative push toward addressing the human condition — which is often found to be shockingly frail.
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Market volatility boosts demand for leveraged and inverse-leveraged ETFs. A few of them gained more than 25% last month.
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Inverse and volatility ETFs won in the worst week of Wall Street since 2020.
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market's worst month of 2024. This has resulted in huge gains for inverse or inverse-leveraged ETFs.
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Last week witnessed the largest collective loss for the "Magnificent Seven" technology-related stocks, with a total of $950 billion erased from their market capitalizations.
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Wall Street delivered a downbeat performance last week.
Since the end of October 2023, the S&P 500 Biotechnology Select Industry Index jumped over 30%. It could maintain its upward trajectory given the early IPO activity in 2024 thus far.
Shorting and inverse bets don't work over time on average, making inverse funds like Direxion Daily S&P Biotech Bear 3X Shares ETF a big avoid. The LABD ETF is a triple-leveraged inverse ETF that focuses on the biotechnology sector and aims to profit from a decline in the value of the index it tracks. LABD is not suitable for long-term investment, incurs high costs, and experiences high volatility, making it a high-risk, high-reward investment.
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Wall Street delivered a decent performance last week.
The U.S. stock market wrapped up October with losses, marking the third-straight monthly decline for the first time since the onset of the COVID pandemic in March 2020.
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Wall Street delivered a downbeat performance last week.
Wall Street gave a mixed performance last week with the S&P 500 and the Nasdaq Composite eking out moderate gains while the Dow Jones and the Russell 2000 slumped.